As the S1PR1 expression level has been previously shown to be elevated in ccRCC tissues and correlated with the progression of clinical stages, we hypothesized that upregulation of miR-363 may inhibit ccRCC malignant progression by attenuating S1PR1 expression. Here, S1PR1 is linked to nonpapillary renal cell carcinoma.